Intrathecal central nervous system prophylaxis in patients with diffuse large B-cell lymphoma at an academic healthcare system

ConclusionGiven the low rates of CNS relapse in this series, it is difficult to discern the impact of current risk stratification combined with intrathecal prophylaxis on outcomes. Our observation that many high-risk patients did not receive prophylaxis while many low-risk patients received prophylaxis emphasizes the need for a standardized approach.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research